Chr. Hansen results beat expectations, colours providing improved ROI
Chr. Hansen’s first quarter results for financial year 2011/12 are a notch stronger than analysts had expected.
Chr. Hansen’s first quarter results for financial year 2011/12 are a notch stronger than analysts had expected.
Supplementation with omega-3 fatty acids may lead to reductions of body fat for obese people, but is only effective over short time frames, according to new research.
People with decreased mental function and Alzheimer’s disease are more likely to have low blood levels of vitamin E tocopherols and tocotrienols, suggest new findings from an international team of researchers.
Momentum behind ChromaDex’s branded antioxidant pTeroPure is continuing to build with growing interest from food manufacturers and new listings for the pTeroPure-based supplement line BluScience at Walgreens.
Danone and Yakult are handing out another $100,000 for research into the role of probiotics and gastrointestinal microbiota in health and wellness.
Dutch firm Newtricious has won undisclosed funding from a local investment consortium that will advance its egg-focused R&D to drive products to shelves in, “two to three years”.
Biotechnology company Entia Biosciences has filed a provisional patent for the use of ingestible and topically applied L-Ergothioneine (Ergo) to maintain and improve hair and nail health, growth, and natural coloring.
70% of Europeans are vitamin D deficient, a situation that is aggravating osteoporosis, loss of motor coordination and bone fractures, researchers have concluded.
Higher levels of omega-3 fatty acids in membranes of red blood cells (erythrocytes) is associated with better mental function in older people recovering from depression, suggests new research.
Consumption of extracts from the Amazonian superfruit açai “markedly” improved the lipid profile and attenuated atherosclerosis in rabbits with diet-induced hypercholesterolemia in a new study from Brazil.